Skip to main content
. Author manuscript; available in PMC: 2008 Feb 23.
Published in final edited form as: Neuroscience. 2006 Dec 19;144(4):1314–1323. doi: 10.1016/j.neuroscience.2006.11.003

Figure 3.

Figure 3

Mean amplitude of the P20 in C57BL/6J mice in each drug condition. Nicotine causes an amplification of the P20 ERP that is reversed by the non-specific nicotinic antagonist mecamylamine. Error bars represent standard error of the mean. Asterisk indicates a significant difference between the drug condition and the saline condition (p<0.05).